Synonyms: SAR-245409 | SAR245409 | XL765
Compound class:
Synthetic organic
Comment: Voxtalisib is an orally bioavailable small molecule inhibitor of phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[4-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methylbenzamide |
International Nonproprietary Names | |
INN number | INN |
9709 | voxtalisib |
Synonyms |
SAR-245409 | SAR245409 | XL765 |
Database Links | |
Specialist databases | |
Reactome Drug | R-ALL-2399863 |
Reactome Reaction | R-HSA-2400009 |
Other databases | |
CAS Registry No. | 934493-76-2 |
GtoPdb PubChem SID | 249565647 |
PubChem CID | 49867926 |
Search Google for chemical match using the InChIKey | HJSSPYJVWLTYHG-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | HJSSPYJVWLTYHG |
Search PubMed clinical trials | voxtalisib |
Search PubMed titles | voxtalisib |
Search PubMed titles/abstracts | voxtalisib |
UniChem Compound Search for chemical match using the InChIKey | HJSSPYJVWLTYHG-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HJSSPYJVWLTYHG-UHFFFAOYSA-N |